MGNX - MacroGenics to Participate in Upcoming Investor Conferences | Benzinga
ROCKVILLE, MD, Aug. 31, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company's management will participate in the following upcoming investor conferences:
- Citi's 18th Annual BioPharma Conference (Boston). Scott Koenig, M.D., Ph.D., MacroGenics' President and CEO, will participate in an ADC/Next Gen Panel Discussion on Wednesday, September 6, 2023, at 10:30 am ET. MacroGenics' management will also participate in ...